🔎 Trials Near Me

Home › Kanser sa Baga › Texas › Irving

Pag-aaral pangklinika para sa Kanser sa Baga sa Irving, TX

6 pag-aaral para sa Kanser sa Baga ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Irving (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Nagre-recruitPhase 3
  • US Oncology Investigational Products Center (IPC), Irving
  • US Oncology Investigational Products Center, Irving
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07222566

A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)

Nagre-recruitPhase 3
  • US Oncology Research Investigational Products Center, Irving
Edad 18 hanggang 100 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT05920356

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

Nagre-recruitPhase 1/2
  • NEXT Oncology - Irving, Irving
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT06618287

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Nagre-recruitPhase 1/2
  • NEXT Dallas, Irving
Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC

Nagre-recruitPhase 1/2
  • NEXT Oncology Dallas, Irving
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 30, 2026 · NCT06162221

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

Nagre-recruitPhase 1/2
  • NEXT Dallas, Irving
Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT06922591

Pag-aaral para sa Kanser sa Baga sa ibang lungsod

Iba pang pag-aaral sa Irving

Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.